Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 2—February 2007

Dispatch

Characteristics of Staphylococcus aureus Infections, Chicago Pediatric Hospital

Preeti Jaggi*, Suzanne M. Paule†, Lance R. Peterson†, and Tina Q. Tan*Comments to Author 
Author affiliations: *Northwestern University, Chicago, Illinois, USA; †Evanston Northwestern Healthcare, Evanston, Illinois, USA;

Main Article

Table 2

Susceptibility data for CA-MRSA isolates from children*

Susceptibility to antimicrobial agent†CA-MRSA isolates causing invasive disease, n (%)CA-MRSA isolates causing local skin/soft tissue infections, n (%)p value
Resistant to erythromycin16/18 (88.9)11/18 (61)NS
Apparently susceptible to clindamycin18/18 (100)18/18 (100)NS
Inducible clindamycin resistance3/16 (19)0/10 (0)NS
Resistant to ciprofloxacin2/18 (11)1/18 (6)NS
Resistant to levofloxacin1/18 (6)1/18 (6)NS
Resistant to tetracycline1/18 (5)2/18 (11)NS

*CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; NS, not significant.
†In addition to the antimicrobial agents listed, all isolates were susceptible to vancomycin, linezolid, and rifampin.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO